The U.S. Food and Drug Administration (FDA) is reviewing whether to change the warning label on hormone replacement therapy (HRT) drugs used to treat menopause symptoms, a move many experts say is long overdue. “We are in serious discussions now about what to do about the black box warning, and I think you’ll hear something… read on > read on >


















